SG11202101973YA - Pneumococcal fusion protein vaccines - Google Patents
Pneumococcal fusion protein vaccinesInfo
- Publication number
- SG11202101973YA SG11202101973YA SG11202101973YA SG11202101973YA SG11202101973YA SG 11202101973Y A SG11202101973Y A SG 11202101973YA SG 11202101973Y A SG11202101973Y A SG 11202101973YA SG 11202101973Y A SG11202101973Y A SG 11202101973YA SG 11202101973Y A SG11202101973Y A SG 11202101973YA
- Authority
- SG
- Singapore
- Prior art keywords
- fusion protein
- protein vaccines
- pneumococcal
- pneumococcal fusion
- vaccines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862730199P | 2018-09-12 | 2018-09-12 | |
PCT/US2019/050800 WO2020056127A1 (en) | 2018-09-12 | 2019-09-12 | Pneumococcal fusion protein vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202101973YA true SG11202101973YA (en) | 2021-03-30 |
Family
ID=69772826
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202101973YA SG11202101973YA (en) | 2018-09-12 | 2019-09-12 | Pneumococcal fusion protein vaccines |
Country Status (13)
Country | Link |
---|---|
US (2) | US20200087361A1 (en) |
EP (1) | EP3849599A4 (en) |
JP (1) | JP2022500409A (en) |
KR (1) | KR20210088535A (en) |
CN (1) | CN113164580A (en) |
AU (1) | AU2019338448A1 (en) |
BR (1) | BR112021004185A2 (en) |
CA (1) | CA3111436A1 (en) |
IL (1) | IL281203A (en) |
MX (1) | MX2021002909A (en) |
SG (1) | SG11202101973YA (en) |
TW (1) | TW202035436A (en) |
WO (1) | WO2020056127A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014124228A1 (en) | 2013-02-07 | 2014-08-14 | Children's Medical Center Corporation | Protein antigens that provide protection against pneumococcal colonization and/or disease |
CN112969474A (en) | 2018-09-12 | 2021-06-15 | 艾芬尼维克斯公司 | Multivalent pneumococcal vaccine |
CA3231684A1 (en) | 2021-09-09 | 2023-03-16 | Affinivax, Inc. | Multivalent pneumococcal vaccines |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3881836A1 (en) * | 2011-05-11 | 2021-09-22 | Children's Medical Center Corporation | Multiple antigen presenting immunogenic composition, and methods and uses thereof |
WO2014018904A1 (en) * | 2012-07-26 | 2014-01-30 | Genocea Biosciences, Inc. | Fused antigen vaccines and compositions against streptococcus pneumoniae |
WO2014124228A1 (en) * | 2013-02-07 | 2014-08-14 | Children's Medical Center Corporation | Protein antigens that provide protection against pneumococcal colonization and/or disease |
CN112969474A (en) * | 2018-09-12 | 2021-06-15 | 艾芬尼维克斯公司 | Multivalent pneumococcal vaccine |
-
2019
- 2019-09-12 KR KR1020217010452A patent/KR20210088535A/en unknown
- 2019-09-12 BR BR112021004185-0A patent/BR112021004185A2/en unknown
- 2019-09-12 JP JP2021513863A patent/JP2022500409A/en active Pending
- 2019-09-12 US US16/568,646 patent/US20200087361A1/en not_active Abandoned
- 2019-09-12 TW TW108133139A patent/TW202035436A/en unknown
- 2019-09-12 CN CN201980073553.0A patent/CN113164580A/en active Pending
- 2019-09-12 SG SG11202101973YA patent/SG11202101973YA/en unknown
- 2019-09-12 AU AU2019338448A patent/AU2019338448A1/en active Pending
- 2019-09-12 EP EP19860907.5A patent/EP3849599A4/en active Pending
- 2019-09-12 MX MX2021002909A patent/MX2021002909A/en unknown
- 2019-09-12 CA CA3111436A patent/CA3111436A1/en active Pending
- 2019-09-12 WO PCT/US2019/050800 patent/WO2020056127A1/en unknown
-
2021
- 2021-03-02 IL IL281203A patent/IL281203A/en unknown
-
2022
- 2022-09-16 US US17/932,685 patent/US20230089151A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CA3111436A1 (en) | 2020-03-19 |
TW202035436A (en) | 2020-10-01 |
AU2019338448A1 (en) | 2021-05-06 |
EP3849599A1 (en) | 2021-07-21 |
JP2022500409A (en) | 2022-01-04 |
MX2021002909A (en) | 2021-09-08 |
CN113164580A (en) | 2021-07-23 |
EP3849599A4 (en) | 2022-06-29 |
BR112021004185A2 (en) | 2021-05-25 |
US20230089151A1 (en) | 2023-03-23 |
KR20210088535A (en) | 2021-07-14 |
WO2020056127A1 (en) | 2020-03-19 |
US20200087361A1 (en) | 2020-03-19 |
IL281203A (en) | 2021-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL265657A (en) | Immunomodulatory fusion proteins | |
ZA201808284B (en) | Gdf15 fusion proteins and uses thereof | |
IL268920A (en) | Peptide vaccines | |
HK1244019A1 (en) | Fusion proteins | |
SG11202011743SA (en) | Fusion proteins comprising progranulin | |
IL251194A0 (en) | Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria | |
GB201509413D0 (en) | Fusion protein | |
HK1246316A1 (en) | Cytokine fusion proteins | |
IL281204A (en) | Multivalent pneumococcal vaccines | |
IL281203A (en) | Pneumococcal fusion protein vaccines | |
GB201504691D0 (en) | Fusion protein | |
SG11202101904UA (en) | Spd-1 variant - fc fusion proteins | |
ZA202003845B (en) | Fusion proteins | |
IL281224A (en) | Peptide vaccines | |
EP3419651C0 (en) | Improved naglu fusion protein formulation | |
IL273626A (en) | Immunomodulatory fusion proteins | |
ZA202102533B (en) | Fusion protein | |
HK1257937A1 (en) | Fusion protein | |
GB201602850D0 (en) | Fusion proteins | |
EP3649159C0 (en) | Fusion protein | |
GB201712792D0 (en) | Fusion protein | |
EP3517542A4 (en) | Dendritic-cell-targeted peptide, fusion peptide utilizing said peptide, and vaccine utilizing said fusion peptide | |
GB201814364D0 (en) | Peptide vaccines | |
GB201814365D0 (en) | Peptide vaccines | |
GB201814366D0 (en) | Peptide vaccines |